Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 2
1976 1
1983 1
1986 7
1987 26
1988 79
1989 149
1990 166
1991 133
1992 148
1993 142
1994 123
1995 116
1996 124
1997 133
1998 120
1999 119
2000 156
2001 131
2002 156
2003 164
2004 143
2005 147
2006 167
2007 185
2008 181
2009 185
2010 197
2011 217
2012 225
2013 205
2014 194
2015 199
2016 193
2017 180
2018 161
2019 90
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

4,706 results
Results by year
Filters applied: . Clear all
Page 1
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.
Giustacchini A, Thongjuea S, Barkas N, Woll PS, Povinelli BJ, Booth CAG, Sopp P, Norfo R, Rodriguez-Meira A, Ashley N, Jamieson L, Vyas P, Anderson K, Segerstolpe Å, Qian H, Olsson-Strömberg U, Mustjoki S, Sandberg R, Jacobsen SEW, Mead AJ. Giustacchini A, et al. Nat Med. 2017 Jun;23(6):692-702. doi: 10.1038/nm.4336. Epub 2017 May 15. Nat Med. 2017. PMID: 28504724
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.
Steegmann JL, Baccarani M, Breccia M, Casado LF, García-Gutiérrez V, Hochhaus A, Kim DW, Kim TD, Khoury HJ, Le Coutre P, Mayer J, Milojkovic D, Porkka K, Rea D, Rosti G, Saussele S, Hehlmann R, Clark RE. Steegmann JL, et al. Leukemia. 2016 Aug;30(8):1648-71. doi: 10.1038/leu.2016.104. Epub 2016 Apr 28. Leukemia. 2016. PMID: 27121688 Free PMC article. Review.
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia.
Branford S, Kim DDH, Apperley JF, Eide CA, Mustjoki S, Ong ST, Nteliopoulos G, Ernst T, Chuah C, Gambacorti-Passerini C, Mauro MJ, Druker BJ, Kim DW, Mahon FX, Cortes J, Radich JP, Hochhaus A, Hughes TP; International CML Foundation Genomics Alliance. Branford S, et al. Leukemia. 2019 Aug;33(8):1835-1850. doi: 10.1038/s41375-019-0512-y. Epub 2019 Jun 17. Leukemia. 2019. PMID: 31209280 Free PMC article. Review.
BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia.
Boissel N, Rea D, Tieng V, Dulphy N, Brun M, Cayuela JM, Rousselot P, Tamouza R, Le Bouteiller P, Mahon FX, Steinle A, Charron D, Dombret H, Toubert A. Boissel N, et al. J Immunol. 2006 Apr 15;176(8):5108-16. doi: 10.4049/jimmunol.176.8.5108. J Immunol. 2006. PMID: 16585609 Free article.
Studying the pathogenesis of BCR-ABL+ leukemia in mice.
Van Etten RA. Van Etten RA. Oncogene. 2002 Dec 9;21(56):8643-51. doi: 10.1038/sj.onc.1206091. Oncogene. 2002. PMID: 12476310 Free article. Review.
Chronic myelogenous leukemia: molecular and cellular aspects.
Pasternak G, Hochhaus A, Schultheis B, Hehlmann R. Pasternak G, et al. J Cancer Res Clin Oncol. 1998;124(12):643-60. doi: 10.1007/s004320050228. J Cancer Res Clin Oncol. 1998. PMID: 9879825 Review.
4,706 results
Jump to page
Feedback